To investigate the features associated with R/R MM survival, we characterized the overall immune status of tumors with five representative immune signatures and found the high level of TGF-β signatures associated with worse outcome in R/R MM tumors. The gene discussed is TGFB1; the disease is Miyoshi myopathy.